Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure
Company Announcements

Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure

Notable Labs, Ltd. (NTBL) has disclosed a new risk, in the Share Price & Shareholder Rights category.

Notable Labs, Ltd., with annual revenues under $100 million and a public float below $700 million, is positioned to leverage reduced disclosure and governance requirements available to smaller reporting companies. This move may diminish the attractiveness of Notable’s ordinary shares to investors due to the potential difficulty in assessing the company’s operational results and financial outlook. An outcome of this could be a less active trading market for Notable’s shares and increased price volatility. The company’s reliance on these scaled-down reporting privileges will persist unless it surpasses the thresholds that categorize it as a smaller reporting entity.

Overall, Wall Street has a Moderate Buy consensus rating on NTBL stock based on 1 Buy.

To learn more about Notable Labs, Ltd.’s risk factors, click here.

Related Articles
GlobeNewswireNotable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
TheFlyNotable Labs receives FDA clearance to proceed further with volasertib study
TheFlyNotable Labs files to sell 19.74M ordinary shares, pre-funded warrants
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!